CASP3 and neoplasm: Immunoblotting of the tumors derived from compound and vehicle-treated mice with the proliferation marker (PCNA) and apoptosis markers (PARP and caspase-3) showed a 50% reduction in tumor cell proliferation upon compound treatment, with no change in apoptosis (Fig.